New Hampshire has postponed a pending trial against drugmaker Johnson & Johnson over opioid distribution and marketing from February to September because of COVID-19 concerns.
The state of New Hampshire was scheduled to face a jury trial on Feb. 2 against Johnson & Johnson and Janssen Pharmaceuticals, Inc.
Eight weeks were allotted for the trial in Merrimack County Superior Court, but lawyers and the judge brought up concerns Friday about delays and too few jury members if participants test positive for the COVID-19 virus.
Jury selection is expected to be held after Labor Day.
Copyright 2026 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Was this article valuable?
Here are more articles you may enjoy.
World’s Growing Civil Unrest Has an Insurance Sting 
Insurify Starts App With ChatGPT to Allow Consumers to Shop for Insurance 
How One Fla. Insurance Agent Allegedly Used Another’s License to Swipe Commissions 
CFC Owners Said to Tap Banks for Sale, IPO of £5 Billion Insurer 
